Protective effects of penehyclidine hydrochloride on septic mice and its mechanism

Shock

Volumn 28, Issue 6, 2007, Pages 727-732

  Zhan, Jia ^a   Wang, Yanlin ^a   Wang, Chengyao ^a   Li, Jianguo ^a   Zhang, Zongze ^a   Jia, Baohui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

iNOS; Malondialdehyde; Penehyclidine hydrochloride; Sepsis; SOD; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LACTIC ACID; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PENEHYCLIDINE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; LUNG PARENCHYMA; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; RAT; SEPSIS;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEART RATE; LIPID PEROXIDATION; LIVER; LUNG; MALONDIALDEHYDE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY ALVEOLI; QUINUCLIDINES; RANDOM ALLOCATION; RNA, MESSENGER; SEPSIS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36248975949     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31805565b1     Document Type: Article

References (33)

1. Muenzer JT, Davis CG, Dunne BS, Unsinger J, Dunne WM, Hotchkiss RS: Pneumonia after cecal ligation and puncture: a clinically relevant "two-hit" model of sepsis. Shock 26:565-570, 2006.
2. Matejovic M, Krouzecky A, Rokyta R Jr, Radej J, Kralova H, Treska V, Radermacher P, Novak I: Effects of combining inducible nitric oxide synthase inhibitor and radical scavenger during porcine bacteremia. Shock 27:61-68, 2007.
3. Song GY, Chung CS, Jarrar D, Cioffi WG, Ayala A: Mechanism of immune dysfunction in sepsis: inducible nitric oxide-meditated alterations in p38 MAPK activation. J Trauma 53:276-283, 2002.
4. Ishii M, Kurachi Y: Muscarinic acetylcholine receptors. Curr Pharm Des 12: 3573-3581, 2006.
5. Calabresi P, Picconi B, Parnetti L, Di Filippo M: A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine- acetylcholine synaptic balance. Lancet Neurol 5:974-983, 2006.
6. Chang-Xing Y, Peng X, Zhi-Hong S, Ying-Li G: Evaluation of anisodamine in clinical pharmacotherapy. Eval Anal Drug Use Hosp China 2:208-210, 2002.
7. Han XY, Liu H, Liu CH, Wu B, Chen LF, Zhong BH, Liu KL: Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). Bioorg Med Chem Lett 15:1979-1982, 2005.
8. Wang YA, Zhou WX, Li JX, Liu YQ, Yue YJ, Zheng JQ, Liu KL, Ruan JX: Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms. Life Sci 78:210-223, 2005.
9. Yi-Jiang T, Jian-Rong C, Jie Z, Jian Y, Kai-Shu L, Yang Z: The clinical applications of penehyclidine hydrochloride in patients with AECOPD. Chin J Emerg Med 15:255-259, 2006.
10. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24:52-57, 2005.
11. Esberg LB, Ren J: The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway: protection by anisodamine and tetramethylpyrazine. Cardiovasc Toxicol 4:375-384, 2004.
12. Xiao-Zhi C: Penehyclidine hydrochloride. Cent S Pharm 1:188-189, 2003.
13. Teng-Fei M, Rong J, Jing Z, Shu-Ling G, Shi-Ming D: Protective effects of penehyclidine hydrochloride on transient forebrain ischemia reperfusion injury in gerbils. Chin J Clin Pharmacol Ther 11:453-457, 2006.
14. Feng-Sheng C, Ji-Yuan H, Zhao-Xing T: Effects of penehyclidine hydrochloride on the expression of nuclear factor-κB in rats after acute global cerebral ischemia/reperfusion. Lingnan J Emerg Med 11:7-9, 2006.
15. Jian-Zhong Q, Shu-lan Y, Zhen-qing Z, Jin-xiu R: Study on pharmacokinetics of penehyclidine hydrochloride in mice. Chin Pharm 38:942-944, 2003.
16. Hildebrand F, Pape HC, Hoevel P, Krettek C, van Griensven M: The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model. Shock 20:338-346, 2003.
17. Cavaillon JM, Annane D: Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12:151-170, 2006.
18. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D: Cytokine cascade in sepsis. Scand J Infect Dis 35:535-544, 2003.
19. Zanotti S, Kumar A, Kumar A: Cytokine modulation in sepsis and septic shock. Expert Opin Investig Drugs 11:1061-1075, 2002.
20. Denninger JW, Marletta MA: Guanylate cyclase and NO/cGMP signaling pathway. Biochim Biophys Acta 1411:334-350, 1999.
21. Kuyumcu A, Duzgun AP, Ozmen MM, Besler HT: The role of nitric oxide in trauma and infection. Ulus Travma Derg 10:149-159, 2004.
22. Korhonen R, Lahti A, Kankaanranta H, Moilanen E: Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4:471-479, 2005.
23. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H: Protective role of endothelial nitric oxide synthase. J Pathol 199:8-17, 2003.
24. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593-615, 2001.
25. Iskit AB, Guc MO: The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock. Eur J Pharmacol 414:281-287, 2001.
26. Collins JL, Vodovotz Y, Hierholzer C, Villavicencio RT, Liu S, Alber S, Gallo D, Stolz DB, Watkins SC, Godfrey A, et al.: Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 19:117-122, 2003.
27. Lin NT, Yang FL, Lee RP, Peng TC, Chen HI: Inducible nitric oxide synthase mediates cytokine release: the time course in conscious and septic rats. Life Sci 78:1038-1043, 2006.
28. Moller K, Skinhoj P: Nitric-oxide synthase inhibitor treatment in septic shock. Ugeskr Laeger 166:1028-1029, 2004.
29. Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K: Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 162:716-722, 2000.
30. Shanley TP, Zhao B, Macariola DR, Denenberg A, Salzman AL, Ward PA: Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit Care Med 30:1960-1968, 2002.
31. Sakaguchi S, Furusawa S: Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 47:167-177, 2006.
32. Gawel S, Wardas M, Niedworok E, Wardas P: Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 57:453-455, 2004.
33. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 97:9753-9758, 2000.